![Alexandre Akoulitchev](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 35 430 $ al 31/05/2026
Alexandre Akoulitchev is the founder of Oxford BioDynamics Plc, founded in 2007, serving as Executive Director & Chief Scientific Officer.
Current job includes Director at Wittgenstean Associates Ltd. Former jobs include Non-Executive Director at Sibelius Ltd. and Director at Chronos Therapeutics Ltd. Education includes a graduate degree from the University of Oxford and a doctorate from University College London.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
OXFORD BIODYNAMICS PLC 0,33 % | 10/11/2025 | 14.228.962 ( 0,33 % ) | 35 430 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| OXFORD BIODYNAMICS PLC | Fundador | 23/04/2007 |
Wittgenstean Associates Ltd. | Director/Miembro de la Junta | - |
| Empresas | Cargo | Fin |
|---|---|---|
Chronos Therapeutics Ltd.
 Chronos Therapeutics Ltd. BiotechnologyHealth Technology Develops therapies in degenerative and behavioral brain diseases | Director/Miembro de la Junta | - |
Sibelius Ltd.
 Sibelius Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and development on natural sciences and engineering | Director/Miembro de la Junta | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 6 |
|---|---|
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University College London
 University College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oxford BioDynamics Plc
 Oxford BioDynamics Plc BiotechnologyHealth Technology Discovers and develops novel biomarkers | Health Technology |
Chronos Therapeutics Ltd.
Chronos Therapeutics Ltd. BiotechnologyHealth Technology Develops therapies in degenerative and behavioral brain diseases | Health Technology |
Sibelius Ltd.
Sibelius Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and development on natural sciences and engineering | Commercial Services |
Wittgenstean Associates Ltd. |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
